Segment Reporting - Summary of Financial Information with Respect to Reportable Segments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment revenues | ||||||
| Total segment revenues | $ 58,889 | $ 54,759 | $ 117,476 | $ 114,310 | ||
| Segment cost of revenues | ||||||
| Total segment cost of revenues | 26,457 | 28,601 | 55,497 | 57,028 | ||
| Segment gross profit: | ||||||
| Total segment gross profit | 32,432 | 26,158 | 61,979 | 57,282 | ||
| Unallocated (expense) income: | ||||||
| Research and development | (40,998) | (43,138) | (84,822) | (88,982) | ||
| Sales and marketing | (10,266) | (10,734) | (21,869) | (21,101) | ||
| General and administrative | (22,715) | (25,189) | (45,629) | (50,991) | ||
| Change in fair value of equity investments | 45,868 | 4,579 | 32,381 | (8,516) | ||
| Other income | 3,026 | 5,438 | 5,689 | 9,642 | ||
| Income tax expense | (1,372) | (287) | (1,780) | (315) | ||
| Consolidated net income (loss) | 5,975 | $ (60,026) | (43,173) | $ (59,808) | (54,051) | (102,981) |
| Software | ||||||
| Segment revenues | ||||||
| Total segment revenues | 35,465 | 40,544 | 71,025 | 89,360 | ||
| Segment cost of revenues | ||||||
| Total segment cost of revenues | 10,538 | 13,029 | 22,838 | 26,551 | ||
| Segment gross profit: | ||||||
| Total segment gross profit | 24,927 | 27,515 | 48,187 | 62,809 | ||
| Drug Discovery | ||||||
| Segment revenues | ||||||
| Total segment revenues | 23,424 | 14,215 | 46,451 | 24,950 | ||
| Segment cost of revenues | ||||||
| Total segment cost of revenues | 15,919 | 15,572 | 32,659 | 30,477 | ||
| Segment gross profit: | ||||||
| Total segment gross profit | $ 7,505 | $ (1,357) | $ 13,792 | $ (5,527) | ||
| X | ||||||||||
- Definition Unallocated. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|